NCT05636826CompletedPhase 2/3
Olive Leaf Extracts in the Control of Hypertension
Efficacy of a Treatment Based on Olive Leaf Extracts in the Control of Cardiovascular Risk Factors:Hypertension
Source: ClinicalTrials.gov · Last updated 7 Jul 2026
Brief summary (registry, in English)
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: Arterial hypertension (hypertension).
- Status (registry)
- Completed
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 500 (actual)
- First submitted
- 23 Nov 2022
- Start date
- 30 Dec 2023
- Primary completion date
- 22 Nov 2024
- Lead sponsor
- University of Monastir
- Diseases
- High blood pressure
- NCT number
- NCT05636826
What you commit to
- Study type: Interventional · Phase 2/3
- Participants enrolled: 500
- From 30 Dec 2023 to the primary completion date, 22 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- . Exclusion criteria: None.
Who the study is looking for
- patients over 18 years of age with:
- Arterial hypertension (hypertension)
Age in the registry: 18 years to 95 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Fattouma Bourguiba Monastir Coordinator of this site? Confirm its status | Monastir | Tunisia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.